ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

IMMX Immix Biopharma Inc

2.06
-0.02 (-0.96%)
15 Jun 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
Immix Biopharma Inc IMMX NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
-0.02 -0.96% 2.06 14:00:10
Open Price Low Price High Price Close Price Previous Close
2.01 2.01 2.26 2.06 2.08
more quote information »

Recent News

Date Time Source Heading
15/6/202407:30EDGAR2Form 8-K - Current report
10/6/202423:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/6/202422:30GLOBERenovoRx Appoints Ryan Witt as Senior Vice President, Head..
05/6/202423:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/6/202423:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/5/202406:05EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
21/5/202407:27EDGAR2Form 8-K - Current report
21/5/202407:27EDGAR2Form D - Notice of Exempt Offering of Securities
21/5/202407:25EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/5/202407:25EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/5/202407:25EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/5/202407:25EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/5/202411:29EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/5/202411:28EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/5/202406:27EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
08/2/202409:15EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
07/2/202401:09EDGAR2Form 8-K - Current report
06/2/202408:38EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
06/2/202408:37EDGAR2Form 8-K - Current report
13/12/202310:25EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/11/202302:48IHNWImmix Biopharma Announces FDA Approval of IND Application..
26/9/202306:15EDGAR2Form S-3 - Registration statement under Securities Act of..
19/9/202309:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/9/202308:27EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/9/202306:58EDGAR2Form 4 - Statement of changes in beneficial ownership of..
31/8/202306:15EDGAR2Form SC 13D - General statement of acquisition of beneficial..
24/8/202306:28EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/8/202306:05EDGAR2Form 8-K - Current report
15/8/202306:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/8/202306:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/8/202306:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/8/202306:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/8/202306:30EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
25/7/202322:42GLOBEImmix Biopharma Subsidiary Nexcella Announces NXC-201..
17/7/202323:37GLOBEImmix Biopharma Reports 2nd Positive Interim Clinical Trial..
15/7/202307:28EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
15/7/202307:26EDGAR2Form 8-K - Current report
10/7/202323:47GLOBEImmix Biopharma Subsidiary Nexcella Completes Initial..
26/6/202323:49GLOBEImmix Biopharma Subsidiary Nexcella Completes Pre-IND..
22/6/202323:53GLOBEImmix Biopharma Subsidiary Nexcella Appoints Edward J...
20/6/202323:45GLOBEImmix Biopharma Subsidiary Nexcella Appoints Jeffrey H...

Your Recent History

Delayed Upgrade Clock